Structural and functional defects of mitochondrial serine hydroxymethyltransferase genetic variants responsible for a novel neurodevelopmental syndrome
Sep 2026· Frontiers in Chemical Biology· Vol 5· 1 citation· 45 references
TL;DR
A systematic biochemical and structural analysis of seven genetic variants of the mitochondrial serine hydroxymethyl transferase linked to a novel brain and heart developmental syndrome is presented and the current understanding of the enzyme’s sophisticated conformational and allosteric dynamics is expanded.
Abstract
In 2020 seven genetic variants of the mitochondrial serine hydroxymethyl transferase (SHMT2) were linked to a novel brain and heart developmental syndrome. SHMT2 is a pyridoxal 5′-phosphate (PLP) binding enzyme involved in one-carbon metabolism and mitochondrial redox homeostasis, which also shows several moonlighting functions and protein-protein interactions that are related to its ability to change its oligomeric state. Molecular dynamics suggested that these genetic variants may cause a range of different structural defects ultimately affecting the conformation of the active site, cofactor affinity and the oligomerization state. Here we present a systematic biochemical and structural analysis of these variants. We expressed and purified the SHMT2 mutants and evaluated their oligomeric state, PLP binding affinity, thermal stability, and catalytic activities compared to the wild-type enzyme. The crystal structures of the less active mutants were then solved to pinpoint the structural determinants of the defects highlighted in solution. The results are discussed considering the multi-functional role of SHMT2 and expand our current understanding of the enzyme’s sophisticated conformational and allosteric dynamics.
Overall, these findings support an effect of the five variants on α-galactosidase A structure and function and highlight the value of integrating clinical, genetic, biochemical, and computational data for variant interpretation.
Monia Anania, V. Pagliardini, Marco Spada et al.· International Journal of Mol...· 0 citations
Deficiency of glucose-6-phosphate dehydrogenase (G6PD) is a hereditary genetic defect which is one of the most prevalent polymorphisms and enzymopathies in humans, affecting approximately 500 million people worldwide. Antimalarial medications, such as primaquine and tafenoquine, have been linked to the hemolysis in the...
Three amino-terminal variants identified in hypoglycemic patients underlie the molecular basis for the clinical variability of AADC deficiency, providing a molecular basis for the clinical variability of AADC deficiency.
Giovanni Bisello, S. K. Uçar, Ayse Yuksel Yanbolu et al.· FEBS Letters· 0 citations
Findings highlight candidate structural determinants for future experimental studies of GBA1-associated neurodegeneration and identify evolutionarily constrained features of GBA1 that may influence its interaction with α-synuclein (SNCA) and thereby contribute to PD pathogenesis.
Sania Mustafa, A. Abbasi, Kashifa Akhtar Mughal et al.· European Journal of Neurosci...· 0 citations
Homocystinuria (HCU) is an inborn error of metabolism and a conformational disorder chiefly caused by the missense mutations in the cystathionine beta-synthase (CBS) gene. These mutations often cause CBS destabilization, misfolding and dysfunction resulting in CBS deficiency and pathological accumulation of homocystein...
Ela Mijatovic, T. M. Philipp, Karim Zuhra et al.· Free Radical Biology & Medic...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.